Ponnazhagan S - Search Results

1

Kumar S, Ponnazhagan S. Kumar S, et al. Among authors: ponnazhagan s. Curr Gene Ther. 2004 Sep;4(3):287-96. doi: 10.2174/1566523043346219. Curr Gene Ther. 2004. PMID: 15384942 Review.

2

Adeno-associated virus for cancer gene therapy.

Ponnazhagan S, Curiel DT, Shaw DR, Alvarez RD, Siegal GP. Ponnazhagan S, et al. Cancer Res. 2001 Sep 1;61(17):6313-21. Cancer Res. 2001. PMID: 11522617 Review. No abstract available.

3

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.

Ponnazhagan S, Mahendra G, Kumar S, Thompson JA, Castillas M Jr. Ponnazhagan S, et al. J Virol. 2002 Dec;76(24):12900-7. doi: 10.1128/jvi.76.24.12900-12907.2002. J Virol. 2002. PMID: 12438615 Free PMC article.

4

Parvovirus vectors for cancer gene therapy.

Ponnazhagan S. Ponnazhagan S. Expert Opin Biol Ther. 2004 Jan;4(1):53-64. doi: 10.1517/14712598.4.1.53. Expert Opin Biol Ther. 2004. PMID: 14680468 Review.

5

Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.

Ponnazhagan S, Mahendra G, Kumar S, Shaw DR, Stockard CR, Grizzle WE, Meleth S. Ponnazhagan S, et al. Cancer Res. 2004 Mar 1;64(5):1781-7. doi: 10.1158/0008-5472.can-03-1786. Cancer Res. 2004. PMID: 14996740

6

Anti-angiogenic gene therapy for cancer (review).

Isayeva T, Kumar S, Ponnazhagan S. Isayeva T, et al. Among authors: ponnazhagan s. Int J Oncol. 2004 Aug;25(2):335-43. Int J Oncol. 2004. PMID: 15254730 Review.

7

Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant.

Ponnazhagan S, Mahendra G, Lima J, Aldrich WA, Jenkins CB, Ren C, Kumar S, Kallman L, Strong TV, Shaw DR, Triozzi PL. Ponnazhagan S, et al. Hum Gene Ther. 2004 Sep;15(9):856-64. doi: 10.1089/hum.2004.15.856. Hum Gene Ther. 2004. PMID: 15353040

8

Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor.

Mahendra G, Kumar S, Isayeva T, Mahasreshti PJ, Curiel DT, Stockardt CR, Grizzle WE, Alapati V, Singh R, Siegal GP, Meleth S, Ponnazhagan S. Mahendra G, et al. Among authors: ponnazhagan s. Cancer Gene Ther. 2005 Jan;12(1):26-34. doi: 10.1038/sj.cgt.7700754. Cancer Gene Ther. 2005. PMID: 15359287

9

Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy.

Kumar S, Mahendra G, Nagy TR, Ponnazhagan S. Kumar S, et al. Among authors: ponnazhagan s. Hum Gene Ther. 2004 Dec;15(12):1197-206. doi: 10.1089/hum.2004.15.1197. Hum Gene Ther. 2004. PMID: 15684696

10

Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.

Aldrich WA, Ren C, White AF, Zhou SZ, Kumar S, Jenkins CB, Shaw DR, Strong TV, Triozzi PL, Ponnazhagan S. Aldrich WA, et al. Among authors: ponnazhagan s. Gene Ther. 2006 Jan;13(1):29-39. doi: 10.1038/sj.gt.3302601. Gene Ther. 2006. PMID: 16136165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page